BEDFORD, Mass., July 12, 2023 Ocular Therapeutix, Inc. , a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and.
The uveitis market is expected to increase owing to the increasing awareness, improved diagnosis, and rising diagnosed prevalent population. In addition, the expected launch of emerging therapies
The ophthalmic drugs market is experiencing optimistic market growth as a result of an increase in the global burden of the geriatric population, increasing cases of various eye disorders and
The ophthalmic drugs market is experiencing optimistic market growth as a result of an increase in the global burden of the geriatric population, increasing.